Skip to content

ESSENZ CPDRecalls & reported problems

LivaNova Deutschland GmbH · Class 2

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 04033817903031), received between Jun 11, 2025 and Oct 22, 2025 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Failure to Auto Stop” (1 report).

1 other recall cover devices cleared under the same FDA submission (K232291); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 2 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Auto Stop1
  • Increased Pump Speed1
  • Pumping Problem1
  • Pumping Stopped1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 22, 2025Pumping Problem; Pumping Problem

    LIVANOVA DEUTSCHLAND RECEIVED REPORT OF AN INTERMITTENT ALARM ("ARTERIAL PUMP DEFECTIVE", 142) REFERRED TO A CENTRIFUGAL PUMP DRIVE MOUNTED ONTO ESSENZ HEART-LUNG MACHINE. THE ISSUE OCCURRED DURING PROCEDURE. THERE WAS NO PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23359878 ↗
  • MalfunctionSep 5, 2025Increased Pump Speed; Increased Pump Speed

    LIVANOVA DEUTSCHLAND RECEIVED A REPORT THAT THE CENTRIFUGE PUMP USED ON ESSENZ HEART LUNG MACHINE (HLM) STARTED ON ITS OWN, DURING PRIMING. THERE WAS NO PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22978840 ↗
  • MalfunctionJun 13, 2025Pumping Stopped; Pumping Stopped

    DURING PREPARATION FOR THE ESSENZ DEMO, AN ALARM OCCURRED FOR "DEVICE (E2911) PUMP FAILURE." THE ALARM HISTORY SHOWS "ART PUMP FAILURE (E142)" AND "ART PUMP PROBLEM (E2353)." PHOTOS AND ERROR LOGS AVAILABLE. THERE WAS NO PATIENT INVOLVEMENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22201342 ↗
  • MalfunctionJun 11, 2025Failure to Auto Stop; Failure to Auto Stop

    LIVANOVA DEUTSCHLAND RECEIVED A REPORT THAT, AT THE END OF THE PROCEDURE, AFTER HAVING RECOVERED PATIENT BLOOD STILL INSIDE THE ARTERY LINE, THE ESSENZ CENTRIFUGAL PUMP BLOCKED AT 1400 RPM SPED AND DIT NOT ALLOW THE OPERATOR TO BRING IT TO 0 RPM. OPERATOR OVERCOME THE PROBLEM AFTER SEVERAL ATTEMPTS. THERE IS NO REPORT OF ANY PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22187026 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K232291. One submission often covers many models, so check the product and lot details in each record.

  • Z-0571-2025 · Oct 18, 2024 · Open, Classified
    Essenz HLM (Heart-Lung Machine), REF: 49-00-10, with Software

Other CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS devices

All CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.